NOX 5.41% 7.0¢ noxopharm limited

Ann: Data Shows Idronoxil Holds Key to Problem of COLD Cancers, page-14

  1. 438 Posts.
    lightbulb Created with Sketch. 211
    I’d be VERY VERY cautious about this announcement and not get carried away by NOX’s claims that it is close to having the first drug that can convert cold to hot tumours. Based on preclinical tests.....Really? Do your own research- there’s plenty of published work in this area to find online - for a start radiotherapy and certain chemotherapies may have this effect, don’t see this as unique to this drug and it’s inappropriate to imply it is unique.
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.